The study aims to assess safety, tolerability and PK of once weekly administration of Elpida in different doses.
A randomized once weekly dose for 8 weeks, study in Healthy HIV-Uninfected Volunteers. Each of 3 parallel groups (40 mg, 80 mg and 160mg) enrolls 12 subjects.